Total Payments
$4,446
2024 Payments
$747.39
Companies
10
Transactions
220
Medicare Patients
1,990
Medicare Billing
$259,645
Payment Breakdown by Category
Food & Beverage$4,446 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,446 | 220 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,524 | 80 | $0 (2024) |
| PFIZER INC. | $1,385 | 78 | $0 (2024) |
| ABBVIE INC. | $693.96 | 32 | $0 (2024) |
| GE HEALTHCARE | $358.35 | 1 | $0 (2018) |
| Lilly USA, LLC | $272.33 | 16 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $97.29 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $48.56 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.50 | 4 | $0 (2018) |
| Genentech USA, Inc. | $18.53 | 1 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $12.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $747.39 | 36 | ABBVIE INC. ($435.65) |
| 2023 | $453.34 | 23 | ABBVIE INC. ($176.97) |
| 2022 | $710.67 | 31 | PFIZER INC. ($307.22) |
| 2021 | $531.29 | 28 | Amgen Inc. ($239.60) |
| 2020 | $147.36 | 8 | PFIZER INC. ($78.42) |
| 2019 | $378.70 | 23 | Amgen Inc. ($170.16) |
| 2018 | $932.80 | 39 | GE HEALTHCARE ($358.35) |
| 2017 | $543.98 | 32 | PFIZER INC. ($261.35) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/25/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $29.23 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Inflammation | ||||||
| 07/31/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Inflammation | ||||||
| 05/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/01/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 436 | 818 | $110,770 | $60,433 |
| 2022 | 9 | 466 | 843 | $118,259 | $61,356 |
| 2021 | 7 | 544 | 1,072 | $161,060 | $78,409 |
| 2020 | 8 | 544 | 986 | $142,500 | $59,448 |
Total Patients
1,990
Total Services
3,719
Medicare Billing
$259,645
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 415 | $65,155 | $37,443 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 219 | $27,375 | $14,194 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $6,860 | $3,266 | 47.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 33 | 60 | $5,700 | $3,080 | 54.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $2,970 | $1,812 | 61.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 42 | 62 | $2,480 | $536.64 | 21.6% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 21 | 23 | $230.00 | $100.99 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 389 | $64,569 | $35,317 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 260 | $33,065 | $16,624 | 50.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $6,730 | $3,209 | 47.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 28 | 53 | $5,805 | $2,608 | 44.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $4,450 | $2,501 | 56.2% |
| 20605 | Aspiration and/or injection of fluid from medium joint | Office | 2022 | 13 | 15 | $1,350 | $623.05 | 46.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 24 | 36 | $1,425 | $313.86 | 22.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 31 | 34 | $680.00 | $115.98 | 17.1% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2022 | 14 | 16 | $185.00 | $43.72 | 23.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 489 | $88,020 | $45,241 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 181 | 304 | $39,520 | $19,988 | 50.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $8,920 | $4,321 | 48.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 40 | 71 | $9,230 | $3,558 | 38.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $9,450 | $3,232 | 34.2% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2021 | 24 | 37 | $3,700 | $1,604 | 43.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 73 | 111 | $2,220 | $465.40 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 165 | 405 | $72,900 | $30,784 | 42.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 170 | 294 | $38,220 | $15,259 | 39.9% |
About Dr. Denny Nakayama, MD
Dr. Denny Nakayama, MD is a Rheumatology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558374066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Denny Nakayama, MD has received a total of $4,446 in payments from pharmaceutical and medical device companies, with $747.39 received in 2024. These payments were reported across 220 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($4,446).
As a Medicare-enrolled provider, Nakayama has provided services to 1,990 Medicare beneficiaries, totaling 3,719 services with total Medicare billing of $259,645. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Honolulu, HI
- Active Since 08/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1558374066
Products in Payments
- XELJANZ (Drug) $1,323
- Enbrel (Biological) $972.69
- RINVOQ (Biological) $603.08
- EVENITY (Biological) $310.05
- TALTZ (Drug) $153.64
- FORTEO (Drug) $118.69
- ORENCIA (Biological) $97.29
- Prolia (Biological) $83.98
- AMJEVITA (Biological) $72.58
- COSENTYX (Biological) $48.56
- Humira (Biological) $47.93
- Uloric (Drug) $47.59
- SKYRIZI (Biological) $28.82
- KRYSTEXXA (Biological) $27.54
- PREVNAR 20 (Biological) $26.32
- Rituxan (Biological) $18.53
- Rinvoq (Biological) $14.13
- LYRICA (Drug) $10.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Honolulu
Dr. Scott Kawamoto, M.d, M.D
Rheumatology — Payments: $79,238
Rheumatology $79,238
Dr. Daniel Brandt, M.d, M.D
Rheumatology — Payments: $39,628
Rheumatology $39,628
Deryll Ambrocio, Md, MD
Rheumatology — Payments: $33,495
Rheumatology $33,495
Dr. Kristine Uramoto, M.d, M.D
Rheumatology — Payments: $27,932
Rheumatology $27,932
Dr. Mari Shiraishi, M.d, M.D
Rheumatology — Payments: $6,717
Rheumatology $6,717
Heejae Jung, Pa-C, PA-C
Rheumatology — Payments: $2,836
Rheumatology $2,836